<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38045316</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>Dysregulated Platelet Function in Patients with Post-Acute Sequelae of COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2023.06.18.545507</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2023.06.18.545507</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Post-acute sequelae of COVID-19 (PASC), also referred as Long-COVID, sometimes follows COVID-19, a disease caused by SARS-CoV-2. While SARS-CoV-2 is well-known to promote a prothrombotic state, less is known about the thrombosis risk in PASC.</AbstractText><AbstractText Label="AIM" NlmCategory="UNASSIGNED">Our objective was to evaluate the platelet function and thrombotic potential in patients following recovery from SARS-CoV-2 with clear symptoms of PASC.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">PASC patients and matched healthy controls were enrolled in the study on average 15 months after documented SARS-CoV-2 infection. Platelet activation was evaluated by Light Transmission Aggregometry (LTA) and flow cytometry in response to platelet surface receptor agonists. Thrombosis in platelet-deplete plasma was evaluated by Factor Xa activity. A microfluidics system assessed thrombosis in whole blood under shear stress conditions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A mild increase in platelet aggregation in PASC patients through the thromboxane receptor was observed and platelet activation through the glycoprotein VI (GPVI) receptor was decreased in PASC patients compared to age- and sex-matched healthy controls. Thrombosis under shear conditions as well as Factor Xa activity were reduced in PASC patients. Plasma from PASC patients was an extremely potent activator of washed, healthy platelets - a phenomenon not observed when stimulating healthy platelets after incubation with plasma from healthy individuals.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">PASC patients show dysregulated responses in platelets and coagulation in plasma, likely caused by a circulating molecule that promotes thrombosis. A hitherto undescribed protective response appears to exists in PASC patients to counterbalance ongoing thrombosis that is common to SARS-CoV-2 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Anu</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Tamanna K</ForeName><Initials>TK</Initials><Identifier Source="ORCID">0000-0002-9591-7860</Identifier></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Godwin</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Rui</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0001-7802-5900</Identifier></Author><Author ValidYN="Y"><LastName>Scalise</LastName><ForeName>Alliefair</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Mina K</ForeName><Initials>MK</Initials><Identifier Source="ORCID">0000-0002-7835-6045</Identifier></Author><Author ValidYN="Y"><LastName>Jennings</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Mariya</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Hiijun</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Englund</LastName><ForeName>Kristin</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Khorana</LastName><ForeName>Alok A</ForeName><Initials>AA</Initials></Author><Author ValidYN="Y"><LastName>Svensson</LastName><ForeName>Lars G</ForeName><Initials>LG</Initials><Identifier Source="ORCID">0000-0002-5749-4588</Identifier></Author><Author ValidYN="Y"><LastName>Kapadia</LastName><ForeName>Samir</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0026-3391</Identifier></Author><Author ValidYN="Y"><LastName>McCrae</LastName><ForeName>Keith R</ForeName><Initials>KR</Initials><Identifier Source="ORCID">0000-0001-7340-475X</Identifier></Author><Author ValidYN="Y"><LastName>Cameron</LastName><ForeName>Scott J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-9616-1540</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Vasc Med. 2024 Apr;29(2):125-134. doi: 10.1177/1358863X231224383</RefSource><PMID Version="1">38334067</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>4</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38045316</ArticleId><ArticleId IdType="pmc">PMC10690211</ArticleId><ArticleId IdType="doi">10.1101/2023.06.18.545507</ArticleId><ArticleId IdType="pii">2023.06.18.545507</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>